Unequivocal evidence of genotoxic potential of argemone oil in mice

Consumption of mustard oil adulterated with argemone oil leads to a clinical condition, commonly referred to as “Epidemic Dropsy.” Since in vitro studies have shown that sanguinarine, an active benzophenanthridine alkaloid of argemone oil, intercalates DNA molecule, the in vivo clastogenic and DNA damaging potential of argemone oil was investigated in mice. Swiss albino mice were intraperitoneally administered 0.5, 1.0, 2.0 and 4.0 ml/kg body wt. of argemone oil to analyze chromosome aberrations and micronucleus test, while 0.25, 0.5, 1.0 and 2.0 ml/kg body wt. were given for alkaline comet assay. The frequencies of chromosomal aberrations and micronucleated erythrocytes formation in mouse bone marrow cells increased in a dose‐dependent manner following argemone oil treatment. However, significant induction in chromosomal aberrations (83%) and micronucleated erythrocytes formation (261%) were observed at a minimum dose of 1.0 ml/kg. The results of comet assay revealed DNA damage in blood, bone marrow and liver cells following argemone oil treatment. Olive tail moment (OTM) and tail DNA showed significant increase in bone marrow (35–44%) and blood cells (25–40%) even at a dose of 0.25 ml/kg body wt. of argemone oil. In liver cells, OTM was significantly increased (20%) at a dose of 0.25 ml/kg, while all the comet parameters including OTM, tail length and tail DNA showed significant increase (31–101%) at a dose of 0.5 ml/kg. These results clearly suggest that single exposure of argemone oil even at low doses produces genotoxic effects in mice. © 2004 Wiley‐Liss, Inc.

[1]  M. Das,et al.  Toxicity of argemone oil: Effect on hsp70expression and tissue damage in transgenic Drosophila melanogaster(hsp70-lacZ) Bg9 , 2004, Cell Biology and Toxicology.

[2]  E. Frei,et al.  DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique. , 2002, Chemico-biological interactions.

[3]  R. Saller,et al.  [Iberis amara L. (bitter candytuft)--profile of a medicinal plant]. , 2002, Forschende Komplementarmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine.

[4]  R. S. Ahmed,et al.  Evaluation of oxidative stress in some cases of argimone oil poisoning during a recent outbreak of epidemic dropsy in India , 2000, International journal of environmental health research.

[5]  S. Gupta,et al.  Induction of chromosome aberrations, micronucleus formation and sperm abnormalities in mouse following carbofuran exposure. , 2000, Mutation research.

[6]  R. Tice,et al.  Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing , 2000, Environmental and molecular mutagenesis.

[7]  I. Munro,et al.  Viadent usage and oral leukoplakia: a spurious association. , 1999, Regulatory toxicology and pharmacology : RTP.

[8]  V. Arlt,et al.  SOS induction of selected naturally occurring substances in Escherichia coli (SOS chromotest). , 1999, Mutation research.

[9]  D. Damm,et al.  Leukoplakia of the maxillary vestibule--an association with Viadent? , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[10]  M. Das,et al.  Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil. , 1997, Critical reviews in toxicology.

[11]  R. Gulati,et al.  Endoscopic biliary endoprosthesis for palliation of gallbladder carcinoma. , 1996, Gastrointestinal endoscopy.

[12]  M. Maiti,et al.  Interaction of sanguinarine iminium and alkanolamine form with calf thymus DNA. , 1994, Biochemical pharmacology.

[13]  R. Klein,et al.  Assessment of genotoxic effects by lindane. , 1993, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  M. Das,et al.  Biometabolic elimination and organ retention profile of argemone alkaloid, sanguinarine, in rats and guinea pigs. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[15]  M. Das,et al.  Biochemical toxicology of argemone oil. I. effect on hepatic cytochrome P‐450 and xenobiotic metabolizing enzymes , 1991, Journal of applied toxicology : JAT.

[16]  M. Das,et al.  Role of antioxidants and scavengers on argemone oil-induced toxicity in rats , 1991, Archives of environmental contamination and toxicology.

[17]  M. Das,et al.  Biochemical toxicology of argemone oil. Role of reactive oxygen species in iron catalyzed lipid peroxidation , 1991, Bulletin of environmental contamination and toxicology.

[18]  G H Strauss,et al.  Non-random cell killing in cryopreservation: implications for performance of the battery of leukocyte tests (BLT), I. Toxic and immunotoxic effects. , 1991, Mutation research.

[19]  M. Berenbaum,et al.  SANGUINARINE, A PHOTOTOXIC H2O2‐PRODUCING ALKALOID , 1989, Photochemistry and photobiology.

[20]  M. Das,et al.  Biochemical toxicology of argemone oil. IV. Short-term oral feeding response in rats. , 1989, Toxicology.

[21]  M. Das,et al.  Biochemical toxicology of argemone alkaloids. III. Effect on lipid peroxidation in different subcellular fractions of the liver. , 1988, Toxicology letters.

[22]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[23]  A. Wijesundere Plant poisons. , 1986, The Ceylon medical journal.

[24]  K. Chaudhuri,et al.  Sanguinarine: a monofunctional intercalating alkaloid , 1982, FEBS letters.

[25]  T. Hsu Cytogenetic assays of environmental mutagens , 1982 .

[26]  W. Schmid The Micronucleus Test for Cytogenetic Analysis , 1976 .

[27]  Robert L. Elston,et al.  Chemical mutagens. Principles and methods for their detection. Volume 2 , 1971 .

[28]  J. Aitchison The Construction of Optimal Designs for the One‐Way Classification Analysis of Variance , 1961 .

[29]  S. Hakim,et al.  Experimental Transmission of Sanguinarine in Milk: Detection of a Metabolic Product , 1961, Nature.

[30]  Carrol S. Weil,et al.  Tables for Convenient Calculation of Median-Effective Dose (LD50 or ED50) and Instructions in their Use. , 1952 .

[31]  S. Sarkar Isolation from Argemone Oil of Dihydrosanguinarine and Sanguinarine: Toxicity of Sanguinarine , 1948, Nature.

[32]  T. C. Rutherfoord An Epidemic of Dropsy , 1908, The Indian medical gazette.